Trial intelligence / Profile preview

Aspirin vs Aspirin + Compression for DVT Prophylaxis in Arthroplasty

NCT02641080Completed

Sponsor
West Virginia University
Start
Jan 2016
Primary completion
Oct 2016
Modality
Orthosteric Ligands
Countries
1
01

Overview

Randomised, open-label trial of aspirin in deep vein thrombosis (DVT) and pulmonary embolism (PE) (2 arms), sponsored by West Virginia University. Primary endpoint: Number of Participants With Venous Thromboembolism at 90 days. Started Jan 2016; status: completed.

02

Drugs

aspirin
03

Conditions

deep vein thrombosis (DVT)pulmonary embolism (PE)

Beyond the preview

Go deeper on NCT02641080.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02641080.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call